Betsi Cadwaladr University Health Board has awarded the main design-and-build contract for a new three-storey, 2,500m² healthcare facility to MTX Contracts.
The project will make extensive use of Modern Methods of Construction (MMC), with MTX delivering the scheme through a two-stage procurement process under a Pre-Construction Service Agreement (PCSA). During this stage, the contractor worked closely with NHS Wales Shared Services Partnership to develop a fully compliant design to RIBA Stage 4.
MTX also collaborated closely with the health board through a series of end-user engagement sessions, ensuring departments that will operate within the building were involved in shaping the design.
The building’s structure will be formed using precisely engineered steel units manufactured offsite while groundwork is underway. This approach is intended to streamline the construction programme and improve efficiency.
Once the foundations and site preparation are complete, the prefabricated modules will be delivered to site, lifted into place by crane and sealed to create a watertight structure. Concrete floor slabs will then be poured, allowing internal fit-out and the installation of mechanical and electrical systems to progress quickly.
Construction is expected to begin within the next few weeks, with completion targeted for 2027.
The scheme forms the first phase of a £60m investment programme at the Royal Alexandra Hospital. A separate business case for the second phase — which will focus on redeveloping and improving the existing hospital facilities — will be submitted by the health board at a later stage.
MTX Contracts Ltd Managing Director David Hartley said: “Being chosen to partner with the health board in the creation of this important healthcare project reflects our strong track record in providing high-quality healthcare facilities across the UK.
“By employing hybrid methods of construction and our own unique skillset, we’re looking forward to delivering this vital new facility quickly, sustainably and cost-effectively, all whilst minimising disruption to existing patient pathways.”
English 